Enterprise-grade phytochemical discovery, chromatographic profiling, in vitro bio-assays, and clinical scale pipeline modules engineered for international compliance.
A structured technical paradigm shift decoupling traditional phytomedicine from unpredictable natural variance through predictive artificial intelligence and advanced bioprocess engineering.
Deploying deep learning molecular docking algorithms and quantitative structure-activity relationship (QSAR) models across vast botanical databases. Our platform accelerates active substance discovery by predicting receptor affinity against target human proteomes before bench synthesis.
Replacing toxic organic solvent extractions with green supercritical fluid systems. Precise thermodynamic control guarantees that thermally labile botanical components—such as terpenes and labile flavonoids—remain structurally intact and chemically pristine.
Formulating active substances with liposomes, solid lipid nanoparticles (SLNs), and cyclodextrin complexes. Overcoming the low water solubility and rapid hepatic first-pass metabolism of critical botanical actives to dramatically heighten in vivo bioavailability.
Harnessing engineered yeast chassis and engineered enzymatic cascades to synthesize rare botanical glycosides and specialized saponins. This route bypasses severe geographical crop limitations and achieves industrial batch scalability independent of weather conditions.
Establishing comprehensive multi-wavelength HPLC, UHPLC-Q-TOF-MS, and 2D-NMR multidimensional chemometric fingerprints. Moving far beyond single-marker assays to establish full holistic chemical identity for unassailable global IP and regulatory dossiers.
Bridging the structural canyon between basic botanical laboratory discovery and commercial multi-ton cGMP production.
Navigating the rigorous preclinical hurdles required for Botanical Drug Applications under US FDA 21 CFR Part 314 and EMA HMPC guidance. MedGence pairs standardized phytochemical fractions with comprehensive Phase I–IV clinical designs, pharmacokinetic (PK/PD) studies, and GLP-compliant toxicological portfolios.
Consumer brand loyalty requires substantiated structure-function claims. We engineer standardized herbal extracts backed by double-blind, randomized, placebo-controlled human clinical trials. We supply ready-to-fill granulated powders, beadlets, and emulsions that ensure shelf stability and organoleptic perfection.
Delivering pure botanical active substances with demonstrated in vitro efficacy against cellular senescence, collagen degradation, and inflammatory melanogenesis. We screen for zero skin sensitization, low heavy-metal impurity loads, and provide total preservative-free bio-active integrity.
Harnessing central China's botanical bio-corridor through automated SCADA-governed extraction columns and full industrial lifecycle control.
Our pilot and large-scale manufacturing facilities operate on automated Distributed Control Systems (DCS). Critical parameters—thermal exposure time, solvent partition ratios, column reflux rates, and vacuum distillation thresholds—are logged real-time, removing human error and securing absolute batch-to-batch consistency.
Located in Changsha, Hunan, MedGence leverages centuries of regional phytomedicinal provenance. We run rigorous soil, altitude, seasonal harvest, and geo-origin (Daodi) evaluation studies across our network of cooperative agricultural bases, verifying maximum active substance yield straight from the soil.
Direct translation from 5L benchtop glass bioreactors and HPLC fraction collectors up to 10-metric-ton continuous multi-effect extractors. We eliminate typical technology transfer delays and yield drops through standardized process analytical technology (PAT).
Comprehensive analytical documentation designed to meet the strict oversight of the US FDA, European EMA, Health Canada, and Australian TGA.
| Regulatory Body / Region | Compliance Mandate | MedGence Technical Deliverable Package | Validation Assays Conducted |
|---|---|---|---|
| United States (US FDA) | 21 CFR Part 111 (Dietary Supplements) & Part 314 (NDAs) | Full Chemistry, Manufacturing, and Controls (CMC) Dossier, Master Batch Records, DMF filings | ICP-MS Heavy Metals, Residual Solvents (USP <467>), Pesticides (USP <561>) |
| European Union (EMA / EFSA) | Traditional Herbal Medicinal Products (THMPD) & Novel Food Regs | Ph. Eur. Monograph Alignment, Active Substance Master File (ASMF), Genotoxic Impurity Profiles | Ames Mutagenicity Test (OECD 471), HPTLC Botanical Chemotaxonomy Fingerprint |
| International (ICH Guidelines) | ICH Q1A (Stability), ICH Q2 (Analytical Validation) | Accelerated & Long-Term 36-Month Real-Time Stability Studies, Zone IVb Climatic Chamber Data | Forced Degradation (Acid, Base, Peroxide, Photostability), Validated HPLC Assays |
| Global Cosmetics (EU CPNP / US MoCRA) | Cosmetic Product Safety Report (CPSR), INCI Identification | Cosmetic Safety Dossier, Human Repeat Insult Patch Test (HRIPT), Microbiological Challenge | In Vitro EpiDerm™ Skin Irritation, Heavy Metals, Zero 1,4-Dioxane / Ethylene Oxide Check |
How MedGence resolves the critical procurement and quality risk factors encountered by international sourcing directors.
We eliminate variations caused by seasonal shift and multi-source wild harvesting. By employing automated blending and chromatographic fingerprint matching, every batch matches validated reference standards down to ±1.5% active marker variance.
Combatting intentional marker adulteration requires comprehensive analytical scrutiny. MedGence leverages Carbon-14 isotopic analysis, HPLC-ESI-MS profiling, and specific chiral chromatography to confirm true natural botanical origin.
Operated strictly as an entrusted contract research and manufacturing organization (CRO/CDMO). Complete custody of formulas, extraction protocols, yield balances, and master cell lines remains 100% exclusive to the sponsor with strict NDA agreements.
In-depth responses from our principal analytical chemists and regulatory affairs team.
Review standard monographs, request analytical method validation data, or initiate custom pilot production batches.
